Endocannabinoid and Psychological Responses to Yoga in Healthy Adults
3 other identifiers
interventional
12
1 country
1
Brief Summary
This study evaluates the acute effect of yoga on plasma levels of endocannabinoids and mood (i.e., mood disturbance, anxiety, pain) compared to one session of quiet rest. Participants completed one session of yoga and one session of quiet rest on two separate days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Dec 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 16, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 16, 2018
CompletedFirst Submitted
Initial submission to the registry
June 21, 2018
CompletedFirst Posted
Study publicly available on registry
October 18, 2018
CompletedResults Posted
Study results publicly available
October 26, 2020
CompletedDecember 8, 2020
November 1, 2020
5 months
June 21, 2018
September 30, 2020
November 16, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Plasma Concentration of N-arachidonoylethanolamine
Plasma concentration of anandamide, one effector of the endocannabinoid system
This will be measured 2 times during each study visit, once before the assigned study task (i.e., baseline) and once upon task completion (i.e., approx. 40 min. later)
Change in Plasma Concentration of 2-Arachidonoylglycerol (2-AG)
Plasma concentration of 2-AG, one effector of the endocannabinoid system
This will be measured 2 times during each study visit, once before the assigned study task (i.e., baseline) and once upon task completion (i.e., approx. 40 min. later)
Secondary Outcomes (3)
Change in Total Mood Disturbance as Measured by the Profile of Mood States
This will be measured 2 times during each study visit, once before the assigned study task (i.e., baseline) and once upon task completion (i.e., approx. 40 min. later)
Change in State Anxiety as Measured by the State-Trait Anxiety Inventory
This will be measured 2 times during each study visit, once before the assigned study task (i.e., baseline) and once upon task completion (i.e., approx. 40 min. later)
Change in Total Pain as Measured by the Short-form McGill Pain Questionnaire
This will be measured 2 times during each study visit, once before the assigned study task (i.e., baseline) and once upon task completion (i.e., approx. 40 min. later)
Study Arms (2)
Yoga
EXPERIMENTAL40 minutes of Vinyasa yoga
Quiet Rest
PLACEBO COMPARATOR40 minutes of quiet rest
Interventions
Eligibility Criteria
You may qualify if:
- greater than or equal to 18 years old and \< 45 years old and
- report being healthy.
You may not qualify if:
- Being pregnant or planning to become pregnant,
- currently smoking,
- having a history of light headedness or fainting during blood draws or physical activity,
- having a history of chest pain during physical activity,
- having a bone, joint, cardiac, or other medical condition that a doctor has said may be worsened by physical activity,
- taking medications for any chronic diseases such as high blood pressure or diabetes,
- responding 'Yes' to any of the seven questions on the Par-Q.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin-Madison Natatorium
Madison, Wisconsin, 53706, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Kelli Koltyn
- Organization
- Univerisity of Wisconsin-Madison
Study Officials
- PRINCIPAL INVESTIGATOR
Kelli Koltyn, PhD
University of Wisconsin, Madison
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2018
First Posted
October 18, 2018
Study Start
December 12, 2017
Primary Completion
May 16, 2018
Study Completion
May 16, 2018
Last Updated
December 8, 2020
Results First Posted
October 26, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share